ABCL logo

AbCellera Biologics Inc. (ABCL) Working capital

annual working capital:

$674.76M-$78.21M(-10.39%)
December 31, 2024

Summary

  • As of today (July 26, 2025), ABCL annual working capital is $674.76 million, with the most recent change of -$78.21 million (-10.39%) on December 31, 2024.
  • During the last 3 years, ABCL annual working capital has fallen by -$134.37 million (-16.61%).
  • ABCL annual working capital is now -25.62% below its all-time high of $907.17 million, reached on December 31, 2022.

Performance

ABCL Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

quarterly working capital:

$689.58M+$14.82M(+2.20%)
March 31, 2025

Summary

  • As of today (July 26, 2025), ABCL quarterly working capital is $689.58 million, with the most recent change of +$14.82 million (+2.20%) on March 31, 2025.
  • Over the past year, ABCL quarterly working capital has dropped by -$19.48 million (-2.75%).
  • ABCL quarterly working capital is now -28.24% below its all-time high of $960.96 million, reached on March 31, 2022.

Performance

ABCL quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

ABCL Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-10.4%-2.8%
3 y3 years-16.6%-28.2%
5 y5 years+10000.0%-

ABCL Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.6%at low-26.6%+4.0%
5 y5-year-25.6%>+9999.0%-28.2%+634.4%
alltimeall time-25.6%>+9999.0%-28.2%>+9999.0%

ABCL Working capital History

DateAnnualQuarterly
Mar 2025
-
$689.58M(+2.2%)
Dec 2024
$674.76M(-10.4%)
$674.76M(+1.7%)
Sep 2024
-
$663.32M(-5.4%)
Jun 2024
-
$701.17M(-1.1%)
Mar 2024
-
$709.07M(-5.8%)
Dec 2023
$752.97M(-17.0%)
$752.97M(-7.0%)
Sep 2023
-
$809.28M(-0.3%)
Jun 2023
-
$811.83M(-4.6%)
Mar 2023
-
$851.06M(-6.2%)
Dec 2022
$907.17M
$907.17M(-3.5%)
DateAnnualQuarterly
Sep 2022
-
$939.62M(+1.8%)
Jun 2022
-
$922.82M(-4.0%)
Mar 2022
-
$960.96M(+18.8%)
Dec 2021
$809.12M(+14.0%)
$809.12M(+7.3%)
Sep 2021
-
$754.20M(-5.0%)
Jun 2021
-
$794.24M(-3.1%)
Mar 2021
-
$819.59M(+15.5%)
Dec 2020
$709.84M(>+9900.0%)
$709.84M(+656.0%)
Sep 2020
-
$93.90M(+1878.8%)
Dec 2019
$4.75M(-45.6%)
$4.75M
Dec 2018
$8.73M
-

FAQ

  • What is AbCellera Biologics Inc. annual working capital?
  • What is the all time high annual working capital for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual working capital year-on-year change?
  • What is AbCellera Biologics Inc. quarterly working capital?
  • What is the all time high quarterly working capital for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly working capital year-on-year change?

What is AbCellera Biologics Inc. annual working capital?

The current annual working capital of ABCL is $674.76M

What is the all time high annual working capital for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual working capital is $907.17M

What is AbCellera Biologics Inc. annual working capital year-on-year change?

Over the past year, ABCL annual working capital has changed by -$78.21M (-10.39%)

What is AbCellera Biologics Inc. quarterly working capital?

The current quarterly working capital of ABCL is $689.58M

What is the all time high quarterly working capital for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly working capital is $960.96M

What is AbCellera Biologics Inc. quarterly working capital year-on-year change?

Over the past year, ABCL quarterly working capital has changed by -$19.48M (-2.75%)
On this page